Who Paid My Doc
Brittany Klein
Dentist, Oral Medicine Boston, MA Doctor of Dentistry
NPI 1114554219 CMS profile 11461521
133 Brookline Ave, Boston, MA 02215
General payments
$28
Research payments
$0
Ownership & investment interest
$0
Through program year 2022, Brittany Klein of Boston, MA is reported in the CMS Open Payments database as having received $28 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $28 | 1 |
Beside peers
- Brittany Klein
- Massachusetts median
- Middle half of Massachusetts
- National median
In program year 2025, general payments to Brittany Klein were reported at $0. Among 21,560 Massachusetts profiles paid that year, the median was $147 and the middle half received between $45 and $552.
Show as a table
| Year | Brittany Klein | Massachusetts median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $133 | $40–$617 | $163 |
| 2020 | $0 | $105 | $32–$540 | $114 |
| 2021 | $0 | $124 | $35–$544 | $132 |
| 2022 | $28 | $126 | $40–$510 | $149 |
| 2023 | $0 | $144 | $47–$542 | $160 |
| 2024 | $0 | $144 | $45–$560 | $164 |
| 2025 | $0 | $147 | $45–$552 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 4 drugsPart D claims
68
Drug cost
$1,866
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Pilocarpine Hcl | Generic | 18 | $947 | |
| Dexamethasone | Generic | 23 | $471 | |
| Nystatin | Generic | 16 | $311 | |
| Clobetasol Propionate | Generic | 11 | $137 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Dentist, Oral Medicine in Massachusetts
Related records
Dentist, Oral Medicine in Massachusetts
Practitioners in the same specialty and state, ranked by reported value.
All Dentist, Oral Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Massachusetts
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.